Emanuele Mazzola

7PUBLICATIONS
51CO-AUTHORS
Molecular targetsHaematological tumoursInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 06, 2026
Presenting features and outcomes to standard systemic therapies in patients with MTAP-deleted advanced non-small cell lung cancer.

|Jan 02, 2026
A Phase 2 Study of Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma.

Gregory M Cote, Mason Aberoumand, Edwin Choy

|Nov 24, 2025
CD8+ T cell recall cytotoxicity during chronic treated HIV-1 infection is associated with limited reservoir size and activity.

David R Collins, Mpho J Olatotse, Jonathan M Urbach

|May 09, 2024
Safety and Efficacy of the Combination Lurbinectedin plus Doxorubicin from a Phase 1b Trial in Patients with Advanced/Metastatic Soft-Tissue Sarcoma.

Gregory M Cote, Candace L Haddox, Edwin Choy

|Jan 18, 2024
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates.

Candace L Haddox, Michael J Nathenson, Emanuele Mazzola

|Mar 29, 2021
Interobserver Variability of Quantitative and Qualitative Assessment Using MRI in Malignant Pleural Mesothelioma.

Ritu R Gill, David J Murphy, Ravi T Seethamraju

Pageof 2

Frequent Collaborators

3 joint publications

Suzanne George

3 joint publications

Priscilla Merriam

3 joint publications

Gregory M Cote

3 joint publications

Edwin Choy